IRAK4-IN-21 |
| Catalog No.GC69288 |
IRAK4-IN-21 (화합물 17)은 경구 투여 가능하며 선택적으로 강력한 IRAK4 억제제로, IRAK4 및 TAK1에 대한 IC50 값이 각각 5 및 56 nM입니다. IRAK4-IN-21은 IL-23 생성을 효과적으로 억제할 수 있으며 (IC50=0.17 μM), 자가면역 질환인 건선과 건선 관절염 연구에 사용될 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170694-04-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for IRAK4-IN-21
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for IRAK4-IN-21
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *